Credit Suisse’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Credit Suisse’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-21,746	Closed	-$999K	–	4769
2015 Q1	$999K	Sell	21,746 -7,909	-27%	-$237K	﹤0.01%	2977
2014 Q4	$712K	Buy	29,655 +4,057	+16%	+$91.5K	﹤0.01%	3435
2014 Q3	$645K	Sell	25,598 -9,739	-28%	-$242K	﹤0.01%	3436
2014 Q2	$922K	Buy	+35,337	New	+$908K	﹤0.01%	3371
2014 Q1	–	Sell	-24,081	Closed	-$486K	–	4977
2013 Q4	$486K	Buy	+24,081	New	+$567K	﹤0.01%	3792

Credit Suisse's HPTX Position: Q2 2015 in Review

Credit Suisse sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 21,746 shares — an estimated $999K sold.

Credit Suisse first reported a position in HPTX in Q4 2013 and held it in 5 quarters. The position peaked at $999K in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

Credit Suisse reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Credit Suisse sold 21,746 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $999K.
Credit Suisse first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q4 2013 and held it in 5 quarters.
Credit Suisse's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $999K in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Credit Suisse's 13F filing for Q2 2015, filed 13 Aug 2015.